202 related articles for article (PubMed ID: 9778752)
21. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
Gorse GJ; Belshe RB; Munn NJ
J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
[TBL] [Abstract][Full Text] [Related]
22. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial.
Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA
Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050
[TBL] [Abstract][Full Text] [Related]
23. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
[TBL] [Abstract][Full Text] [Related]
24. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
25. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
Kashirina OS; Vasil'ev IuM
Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
[TBL] [Abstract][Full Text] [Related]
26. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
Steinhoff MC; Halsey NA; Wilson MH; Burns BA; Samorodin RK; Fries LF; Murphy BR; Clements ML
J Infect Dis; 1990 Aug; 162(2):394-401. PubMed ID: 2197335
[TBL] [Abstract][Full Text] [Related]
27. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.
Murphy BR; Coelingh K
Viral Immunol; 2002; 15(2):295-323. PubMed ID: 12081014
[No Abstract] [Full Text] [Related]
28. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
[TBL] [Abstract][Full Text] [Related]
29. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers.
Clements ML; Snyder MH; Sears SD; Maassab HF; Murphy BR
J Infect Dis; 1990 May; 161(5):869-77. PubMed ID: 2324538
[TBL] [Abstract][Full Text] [Related]
31. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
[TBL] [Abstract][Full Text] [Related]
32. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children.
Edwards KM; King JC; Steinhoff MC; Thompson J; Clements ML; Wright PF; Murphy BR
J Infect Dis; 1991 Apr; 163(4):740-5. PubMed ID: 2010627
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of inactivated and live attenuated influenza vaccines.
Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of live attenuated cold-adapted influenza B/Yamagata/16/88 reassortant virus vaccine in healthy adults.
Treanor JJ; Betts RF
J Infect Dis; 1993 Aug; 168(2):455-9. PubMed ID: 8335984
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents.
Rudenko LG; Arden NH; Grigorieva E; Naychin A; Rekstin A; Klimov AI; Donina S; Desheva J; Holman RC; DeGuzman A; Cox NJ; Katz JM
Vaccine; 2000 Sep; 19(2-3):308-18. PubMed ID: 10930686
[TBL] [Abstract][Full Text] [Related]
37. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.
Song JY; Cheong HJ; Lee J; Woo HJ; Wie SH; Lee JS; Kim SW; Noh JY; Choi WS; Kim H; Kim KH; Kim WJ
Vaccine; 2015 Oct; 33(41):5437-5444. PubMed ID: 26314625
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
